- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
14
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
14 companies
Lytix Biopharma
Market Cap: NOK 491.5m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 7.20
7D
2.6%
1Y
-1.9%
Thor Medical
Market Cap: NOK 1.3b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 3.57
7D
-19.6%
1Y
208.8%
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 25.70
7D
0.8%
1Y
45.4%
Nykode Therapeutics
Market Cap: NOK 539.5m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.65
7D
5.0%
1Y
-64.4%
Zelluna
Market Cap: NOK 256.2m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 12.53
7D
-0.6%
1Y
n/a
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.30
7D
-3.7%
1Y
7.7%
SoftOx Solutions
Market Cap: NOK 184.9m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.082
7D
-3.8%
1Y
331.6%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
95.2%
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.20
7D
-2.1%
1Y
-18.9%
Navamedic
Market Cap: NOK 383.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.70
7D
3.3%
1Y
-29.3%
PCI Biotech Holding
Market Cap: NOK 12.2m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.33
7D
-9.2%
1Y
-81.8%
EXACT Therapeutics
Market Cap: NOK 126.5m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 2.00
7D
-9.1%
1Y
-65.2%
BerGenBio
Market Cap: NOK 48.5m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.24
7D
4.4%
1Y
-87.1%
Oncoinvent
Market Cap: NOK 136.8m
A clinical stage company, develops radiopharmaceutical therapies against cancer.
ONCIN
NOK 1.40
7D
-10.8%
1Y
n/a